Download the recommended reading list here

 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL RECOMMENDED READING LIST: It is recommended that the course participants familiarize themselves with the following guidelines, white papers, and key articles. By clicking on the blue link below each citation, you will be able to directly access the reading material. In the event articles are added, an updated list will be provided to each registrant. GUIDELINES AND POLICY STATEMENTS American College of Cardiology/American Heart Association 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;June 5: S0735‐1097 http://circ.ahajournals.org/content/early/2013/06/03/CIR.0b013e31829e8776 Prevention of Heart Failure: A Scientific Statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circ 2008;117:2544‐2565 http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.107.188965.pdf 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57‐e185 http://content.onlinejacc.org/article.aspx?articleid=1838843 Transitions of Care in Heart Failure: A Scientific Statement From the American Heart Association on behalf of the American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research, Circ: Heart Failure. 2015;8:384‐409 http://circheartfailure.ahajournals.org/content/8/2/384.full ACC/AHA and ESC ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation Executive Summary (2006) Circ 2006;114:700‐752 http://circ.ahajournals.org/cgi/reprint/114/7/700 The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circ 2007;116:2216‐2233 http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.107.186093.pdf ACC/AHA and Heart Rhythm Society ACC/AHA/HRS 2008 Guidelines for Device‐Based Therapy of Cardiac Rhythm Abnormalities http://www.hrsonline.org/Policy/ClinicalGuidelines/upload/DBT08_guidelines_full.pdf http://www.hrsonline.org/Policy/ClinicalGuidelines/upload/devicebased_therapy.pdf (Executive Summary) A Practical Guide for Clinicians Who Treat Patients with Amiodarone (2007) See under heading for “Arrhythmias, CRM Devices, and Leads” Heart Rhythm 2007;4:1250+090‐1259 http://www.hrsonline.org/Policy/ClinicalGuidelines/upload/Amiodarone‐Guide‐2007.pdf Resynchronization Therapy for Heart Failure (2005) http://www.hrsonline.org/Policy/ClinicalGuidelines/upload/resynch_therapy_HF.pdf Heart Failure Society of America Heart Failure Society of America (HFSA) 2010 Comprehensive Heart Failure Practice Guideline J Cardiac Fail 2010;16:e1‐e194 http://www.heartfailureguideline.org/ HFSA 2010 Comprehensive Heart Failure Practice Guideline Executive Summary J Card Fail 2010:16;175‐539 http://download.journals.elsevierhealth.com/pdfs/journals/1071‐9164/PIIS107191641000740.pdf The Genetic Evaluation of Cardiomyopathy: A Heart Failure Society of America Practice Guideline J Card Fail 2009;25:83‐97 http://download.journals.elsevierhealth.com/pdfs/journals/1071‐9164/PIIS1071916409000281.pdf International Society for Heart and Lung Transplantation 2009 ESC/ERS Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension European Heart J 2009;30:2493‐2537 http://www.escardio.org/guidelines‐surveys/esc‐guidelines/GuidelinesDocuments/guidelines‐PH‐FT.pdf Page 1 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL (Guidelines and Policy Statements continued) Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates; 2006 J Heart Lung Transplant 2006;25:1024‐42 http://download.journals.elsevierhealth.com/pdfs/journals/1053‐2498/PIIS1053249806004608.pdf Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates; 2006 J Heart Lung Transplant 2006;25:1043‐1056 http://download.journals.elsevierhealth.com/pdfs/journals/1053‐2498/PIIS1053249806004578.pdf Optimal Pharmacologic and Non‐pharmacologic Management of Cardiac Transplant Candidates: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates; 2006 J Heart Lung Transplant 2006:25:1003‐1023 http://download.journals.elsevierhealth.com/pdfs/journals/1053‐2498/PIIS1053249806004591.pdf The International Society of Heart and Lung Transplantation Guidelines for the Care of Heart Transplant Recipients. Costanzo MR (Chair) et al. J Heart Lung Transplant 2010; 29: 914‐56. The full document is available on the ISHLT website: http://www.ishlt.org/publications/guidelines.asp KEY ARTICLES Acute Heart Failure 1.
2.
Emerging therapies for the management of decompensated heart failure: from bench to bedside. deGoma EM, Vagelos RH, Fowler MB, Ashley EA. J Am Coll Cardiol. 2006 Dec 19;48(12):2397‐409. Epub 2006 Nov 28. Review. http://tinyurl.com/2chkg2r Acute heart failure syndromes. Gheorghiade M, Pang PS. J Am Coll Cardiol. 2009 Feb 17;53(7):557‐73. Review. http://tinyurl.com/33emvym 3.
4.
5.
6.
Can We Predict and Prevent the Onset of Acute Decompensated Heart Failure? Eugene E. Wolfel Circulation 2007;116;1526‐1529 http://circ.ahajournals.org/cgi/content/full/116/14/1526 Transition From Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures Michael R. Zile, MD; Tom D. Bennett, PhD; Martin St. John Sutton, MD; Yong K. Cho, PhD; Philip B. Adamson, MD; Mark F. Aaron, MD; Juan M. Aranda Jr, MD; William T. Abraham, MD; Frank W. Smart, MD; Lynne Warner Stevenson, MD; Fred J. Kueffer, MS, MD; Robert C. Bourge, MD Circulation 2008, 118:1433‐1441 http://circ.ahajournals.org/content/118/14/1433 Decision Making in Advanced Heart Failure: A Scientific Statement from the American Heart Association. Allen LA, Stevenson LW, Grady KL, et al. (March 2012 Circulation) http://tinyurl.com/74uuafq Effect of Nesiritide in Patients with Acute Decompensated Heart Failure C.M. O’Connor, R.C. Starling, A.F. Hernandez, P.W. Armstrong, K. Dickstein, V. Hasselblad, G.M. Heizer, M. Komajda, B.M. Massie, J.J.V. McMurray, M.S. Nieminen, C.J. Reist, J.L. Rouleau, K. Swedberg, K.F. Adams, Jr., S.D. Anker, D. Atar, A. Battler, R. Botero, N.R. Bohidar, J. Butler, N. Clausell, R. Corbalán, M.R. Costanzo, U. Dahlstrom, L.I. Deckelbaum, R. Diaz, M.E. Dunlap, J.A. Ezekowitz, D. Feldman, G.M. Felker, G.C. Fonarow, D. Gennevois, S.S. Gottlieb, J.A. Hill, J.E. Hollander, J.G. Howlett, M.P. Hudson, R.D. Kociol, H. Krum, A. Laucevicius, W.C. Levy, G.F. Méndez, M. Metra, S. Mittal, B.‐H. Oh, N.L. Pereira, P. Ponikowski, W.H. Wilson, S. Tanomsup, J.R. Teerlink, F. Triposkiadis, R.W. Troughton, A.A. Voors, D.J. Whellan, F. Zannad, and R.M. Califf. N Engl J Med 2011;365:32‐43. http://www.nejm.org/doi/full/10.1056/NEJMoa1100171 Arrhythmias and Implantable Devices 1.
2.
Atrial fibrillation and acute decompensated heart failure. DiMarco JP. Circ Heart Fail. 2009 Jan;2(1):72‐3. Review. No abstract available. http://circheartfailure.ahajournals.org/cgi/reprint/2/1/72.pdf The efficacy of implantable cardioverter‐defibrillators in heart transplant recipients: results from a multicenter registry. Tsai VW, Cooper J, Garan H, Natale A, Ptaszek LM, Ellinor PT, Hickey K, Downey R, Zei P, Hsia H, Wang P, Hunt S, Haddad F, Al‐Ahmad A. Circ Heart Fail. 2009 May;2(3):197‐201. Epub 2009 Apr 30. http://circheartfailure.ahajournals.org/cgi/reprint/2/3/197.pdf Page 2 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL 3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Resynchronization therapy for the treatment of heart failure. Saxon LA, Ellenbogen KA. Circulation. 2003 Sep 2;108(9):1044‐8. Review. No abstract available. http://circ.ahajournals.org/cgi/reprint/108/9/1044.pdf Heart failure and sudden death in patients with tachycardia‐induced cardiomyopathy and recurrent tachycardia. Nerheim P, Birger‐Botkin S, Piracha L, Olshansky B. Circulation. 2004 Jul 20;110(3):247‐52. Epub 2004 Jun 28. http://circ.ahajournals.org/cgi/reprint/110/3/247.pdf Management of atrial fibrillation in patients with heart failure. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA, Böhm M. Eur Heart J. 2007 Nov;28(21):2568‐77. Epub 2007 Sep 13. Review. http://eurheartj.oxfordjournals.org/content/28/21/2568.full.pdf Rhythm control versus rate control for atrial fibrillation and heart failure. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL; Atrial Fibrillation and Congestive Heart Failure Investigators. N Engl J Med. 2008 Jun 19;358(25):2667‐77. http://content.nejm.org/cgi/reprint/358/25/2667.pdf Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Klein MH, Gold MR. Cardiol Clin. 2008 Aug;26(3):419‐31, vi‐vii. Review. http://www.ncbi.nlm.nih.gov/pubmed/18538188 Problems with implantable cardiac device therapy. Kowalski M, Huizar JF, Kaszala K, Wood MA. Cardiol Clin. 2008 Aug;26(3):441‐58, vii. Review. http://www.ncbi.nlm.nih.gov/pubmed/18538190 Troubleshooting pacemakers and implantable cardioverter‐defibrillators. Scher DL. Curr Opin Cardiol. 2004 Jan;19(1):36‐46. Review. http://www.ncbi.nlm.nih.gov/pubmed/14688633 Pathobiology of cardiac dyssynchrony and resynchronization. Kass DA. Heart Rhythm. 2009 Nov;6(11):1660‐5. Epub 2009 Aug 14. Review. http://www.ncbi.nlm.nih.gov/pubmed/19879547 A Meta‐Analysis of Remote Monitoring of Heart Failure Patients Catherine Klersy, Annalisa De Silvestri, Gabriella Gabutti, François Regoli, and Angelo Auricchio J. Am. Coll. Cardiol. 2009;54;1683‐1694 http://content.onlinejacc.org/cgi/content/full/54/18/1683 Supraventricular tachycardia after orthotopic cardiac transplantation. Vaseghi M, Boyle NG, Kedia R, Patel JK, Cesario DA, Wiener I, Kobashigawa JA, Shivkumar K.J Am Coll Cardiol. 2008 Jun 10;51(23):2241‐9. http://tinyurl.com/3xwcn6k Catheter ablation of supraventricular tachycardia in the transplanted heart: a case series and literature review. Magnano AR, Garan H. Pacing Clin Electrophysiol. 2003 Sep;26(9):1878‐86. Review. http://www.ncbi.nlm.nih.gov/pubmed/12930504 Biomarkers 1.
2.
Biomarkers in heart failure. Braunwald E. N Engl J Med. 2008 May 15;358(20):2148‐59. Review. No abstract available. http://www.ncbi.nlm.nih.gov/pubmed/18480207 Rapid measurement of B‐type natriuretic peptide in the emergency diagnosis of heart failure. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. N Engl J Med. 2002 Jul 18;347(3):161‐7. http://content.nejm.org/cgi/reprint/347/3/161.pdf Page 3 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL Cardiac Surgery in Heart Failure Patients 1.
2.
3.
4.
5.
Coronary artery bypass grafting in patients with low ejection fraction. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB, Argenziano M, Naka Y, Oz MC, Esrig BC. Circulation. 2005 Aug 30;112:I344‐50. http://circ.ahajournals.org/cgi/reprint/112/9_suppl/I‐344.pdf The use of contrast‐enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. N Engl J Med. 2000 Nov 16;343(20):1445‐53. http://content.nejm.org/cgi/reprint/343/20/1445.pdf Comparison of coronary artery bypass grafting versus medical therapy on long‐term outcome in patients with ischemic cardiomyopathy (a 25‐year experience from the Duke Cardiovascular Disease Databank). O'Connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, Lee KL, Califf RM, Jones RH. Am J Cardiol. 2002 Jul 15;90(2):101‐7. http://www.ncbi.nlm.nih.gov/pubmed/12106836 Revascularization for heart failure. Phillips HR, O'Connor CM, Rogers J. Am Heart J. 2007 Apr;153(4 Suppl):65‐73. Review. http://www.ncbi.nlm.nih.gov/pubmed/17394905 Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, Jessup M, Sabbah HN, Starling RC, Kubo SH; Acorn Trial Principal Investigators and Study Coordinators. J Thorac Cardiovasc Surg. 2006 Sep;132(3):568‐77, 577.e1‐4. Epub 2006 Jul 31. http://www.ncbi.nlm.nih.gov/pubmed/16935112 Cardiac Transplantation (Also see ISHLT guidelines and articles under "Immunosuppression") 1.
2.
3.
Transplant coronary artery disease. Zimmer RJ, Lee MS. JACC Cardiovasc Interv. 2010 Apr;3(4):367‐77. http://www.ncbi.nlm.nih.gov/pubmed/20398862 Use of rapamycin slows progression of cardiac transplantation vasculopathy. Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. Circulation. 2003 Jul 8;108(1):48‐53. Epub 2003 May 12. http://circ.ahajournals.org/cgi/reprint/108/1/48.pdf Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta‐analysis. Ye F, Ying‐Bin X, Yu‐Guo W, Hetzer R. J Heart Lung Transplant. 2009 Jan;28(1):58‐66. Epub 2008 Dec 4. http://www.ncbi.nlm.nih.gov/pubmed/19134532 Clinical Assessment 1.
Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure: The ESCAPE Trial Drazner MH, Hellkamp AS, Leier CV, Shah MR, Miller LM, Russell SD. Circ Heart Fail. 2008; 1: 170–177 http://circheartfailure.ahajournals.org/content/1/3/170.long Disease Management and End‐of‐Life Care 1.
2.
3.
4.
The heart failure clinic: a consensus statement of the Heart Failure Society of America. Hauptman PJ, Rich MW, Heidenreich PA, Chin J, Cummings N, Dunlap ME, Edwards ML, Gregory D, O’connor CM, Pezzella SM, Philbin E; Heart Failure Society of America. J Card Fail. 2008 Dec;14(10):801‐15. Review. http://download.journals.elsevierhealth.com/pdfs/journals/1071‐9164/PIIS1071916408010129.pdf Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Eur J Heart Fail. 2005 Dec;7(7):1133‐44. Epub 2005 Sep 29. http://eurjhf.oxfordjournals.org/content/7/7/1133.full.pdf Efficacy and safety of exercise training in patients with chronic heart failure: HF‐ACTION randomized controlled trial. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF‐ACTION Investigators. JAMA. 2009 Apr 8;301(14):1439‐50. http://jama.ama‐assn.org/cgi/content/full/301/14/1439 Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance David C. Poole, Daniel M. Hirai, Steven W. Copp, and Timothy I. Musch. Am J Physiol Heart Circ Physiol 2012; 302: H1050 Page 4 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL 5.
http://ajpheart.physiology.org/content/ajpheart/302/5/H1050.full.pdf Role and benefits of exercise in the management of patients with heart failure. Keteyian SJ1, Fleg JL, Brawner CA, Piña IL. Heart Fail Rev. 2010 Nov;15(6):523‐30. http://www.ncbi.nlm.nih.gov/pubmed/20101456 6.
7.
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure: HF‐ACTION Randomized Controlled Trial Christopher M. O’Connor, MD, David J. Whellan, MD, MHS, Kerry L. Lee, PhD, Steven J. Keteyian, PhD, Lawton S. Cooper, MD, MPH, Stephen J. Ellis, PhD, Eric S. Leifer, PhD, William E. Kraus, MD, Dalane W. Kitzman, MD, James A. Blumenthal, PhD, David S. Rendall, PA‐C, Nancy Houston Miller, RN, BSN, Jerome L. Fleg, MD, Kevin A. Schulman, MD, Robert S. McKelvie, MD, PhD, Faiez Zannad, MD, PhD, and Ileana L. Piña, MD, for the HF‐ACTION Investigators. JAMA. 2009;301(14):1439‐1450. http://jama.jamanetwork.com/article.aspx?articleid=183708 Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines‐Heart Failure Registry. Golwala H, Pandey A, Ju C, Butler J, Yancy C, Bhatt DL, Hernandez AF, Fonarow. J Am Coll Cardiol. 2015 Aug 25;66(8):917‐26. http://www.ncbi.nlm.nih.gov/pubmed/26293762 8.
9.
10.
11.
12.
13.
14.
15.
Consensus Statement: End‐of‐life care in patients with heart failure Whellan DJ, Goodlin SJ, Dickinson MG et al. J Card Failure 2014;20(2):121‐134 http://www.ncbi.nlm.nih.gov/pubmed/24556532 Compendium of Treatment of End Stage Non‐Cancer Diagnoses: Heart Failure Fahlber BB, Panke JT. 2011. 2ND Edition by Hospice and Palliative Care Nurses Association.Pittsburgh, PA http://www.hpna.org/HPNA_Item_Details.aspx?ItemNo=978‐1‐934654‐24‐8 Palliative care in congestive heart failure. Goodlin SJ. J Am Coll Cardiol. 2009 Jul 28;54(5):386‐96. Review. http://www.ncbi.nlm.nih.gov/pubmed/19628112 Palliative care in the treatment of advanced heart failure. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Circulation. 2009 Dec 22;120(25):2597‐606. Review. No abstract available. http://circ.ahajournals.org/cgi/content/extract/120/25/2597 Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Inglis SC, Clark RA, McAlister FA et al. Cochrane Database Syst. Rev 2010:CD007228. A meta‐analysis of remote monitoring of heart failure patients. Klersy C, De Silvestri A, Gabutti G, Ragoli F, Auricchio A. J Am Coll Cardiol 2009;54:1683‐94. Do heart failure disease management programs make financial sense under a bundled payment system? Eapen ZJ, Reed SD, Curtis LH, Hernandez AF, Peterson ED. Am Heart J 2011;161:916‐22. Diuretic Strategies in Patients with Acute Decompensated Heart Failure G. Michael Felker, Kerry L. Lee, David A. Bull, Margaret M. Redfield, Lynne W. Stevenson, Steven R. Goldsmith, Martin M. LeWinter, Anita Deswal, Jean L. Rouleau, Elizabeth O. Ofili, Kevin J. Anstrom, Adrian F. Hernandez, Steven E. McNulty, Eric J. Velazquez, Abdallah G. Kfoury, Horng H. Chen, Michael M. Givertz, Marc J. Semigran, Bradley A. Bart, Alice M. Mascette, Eugene Braunwald, and Christopher M. O’Connor, for the NHLBI Heart Failure Clinical Research Network. N Engl J Med 2011;364:797‐805. http://www.nejm.org/doi/full/10.1056/NEJMoa1005419 Epidemiology and Risk Factors 1.
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2008 May 13;117(19):2544‐65. Epub 2008 Apr 7. http://circ.ahajournals.org/cgi/reprint/117/19/2544.pdf Page 5 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL 2.
3.
Disease‐specific health‐related quality of life questionnaires for heart failure: a systematic review with meta‐analyses. Garin O, Ferrer M, Pont A, Rué M, Kotzeva A, Wiklund I, Van Ganse E, Alonso J. Qual Life Res. 2009 Feb;18(1):71‐85. Epub 2008 Dec 4. Review. http://www.ncbi.nlm.nih.gov/pubmed/19052916 Multivariate risk scores and patient outcomes in advanced heart failure. Ketchum ES, Levy WC. Congest Heart Fail. 2011 Sep‐Oct;17(5):205‐12 http://tinyurl.com/743opgb Hypertrophic Cardiomyopathy 1.
2.
3.
4.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic CM: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. J Thorac Cardiovasc Surg. 2011 Dec;142(6):e153‐203. http://content.onlinejacc.org/cgi/content/full/j.jacc.2011.06.011 Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. J Am Coll Cardiol. 2000 Dec;36(7):2212‐8. http://tinyurl.com/2vw45d9 Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Ommen SR, Shah PM, Tajik AJ. Heart. 2008 Oct;94(10):1276‐81. Epub 2008 Jul 24. Review. No abstract available. http://www.ncbi.nlm.nih.gov/pubmed/18653577 Hypertrophic cardiomyopathy: a systematic review. Maron BJ. JAMA. 2002 Mar 13;287(10):1308‐20. http://jama.jamanetwork.com/article.aspx?articleid=194713 Imaging 1.
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: an executive summary: a joint report of the ACR Appropriateness Criteria ® Committee and the ACCF Appropriate Use Criteria Task Force. White RD, Patel MR, Abbara S, Bluemke DA, Herfkens RJ, Picard M, Shaw LJ, Silver M, Stillman AE, Udelson J. J Am Coll Radiol. 2013 Jul;10(7):493‐500. http://www.acr.org/~/media/ACR/Documents/AppCriteria/AUI%20Heart%20Failure%20Manuscript%20Final%202013JUNE13.pdf Immunosuppression 1.
2.
Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J. Circulation. 2004 Dec 14;110(24):3734‐40. Review. No abstract available. http://circ.ahajournals.org/cgi/reprint/110/24/3734.pdf Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J. Circulation. 2004 Dec 21;110(25):3858‐65. Review. No abstract available. http://circ.ahajournals.org/cgi/reprint/110/25/3858.pdf 3.
4.
Drug therapy in the heart transplant recipient: Part III: common medical problems. Lindenfeld J, Page RL 2nd, Zolty R, Shakar SF, Levi M, Lowes B, Wolfel EE, Miller GG. Circulation. 2005 Jan 4;111(1):113‐7. Review. No abstract available. http://circ.ahajournals.org/cgi/reprint/111/1/113.pdf Drug therapy in the heart transplant recipient: Part IV: drug‐drug interactions. Page RL 2nd, Miller GG, Lindenfeld J. Circulation. 2005 Jan 18;111(2):230‐9. Review. No abstract available. http://circ.ahajournals.org/cgi/reprint/111/2/230.pdf Mechanical Circulatory Support 1.
Evaluation for a ventricular assist device: selecting the appropriate candidate. Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM. Circulation. 2009 Apr 28;119(16):2225‐32. Review. No abstract available. Full article: http://circ.ahajournals.org/cgi/reprint/119/16/2225.pdf Page 6 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL 2.
The Fourth INTERMACS Annual Report: 4,000 implants and counting. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. J Heart Lung Transplant. 2012;31:117‐26. http://tinyurl.com/6qmppnr Mechanical Circulatory Support: Post‐operative Management 1.
Clinical management of continuous‐flow left ventricular assist devices in advanced heart failure. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ; HeartMate II Clinical Investigators. J Heart Lung Transplant. 2010 Apr;29(4 Suppl):S1‐39. Epub 2010 Feb 24. http://www.ncbi.nlm.nih.gov/pubmed/20181499 Mitral Regurgitation 1.
SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement. Part II. Mitral Valve Carl L. Tommaso, David A. Fullerton,Ted Feldman, Larry S. Dean, Ziyad M. Hijazi,Eric Horlick, Bonnie H. Weiner, Evan Zahn, Joaquin E. Cigarroa, Carlos E. Ruiz, Joseph Bavaria, Michael J. Mack,Duke E. Cameron, R. Morton Bolman, III, D. Craig Miller, Marc R. Moon, Debabrata Mukherjee, Alfredo Trento, Gabriel S. Aldea, Emile A. Bacha. J Am Coll Cardiol. 2014;64(14):1515‐1526 http://content.onlinejacc.org/article.aspx?articleid=1872608 2.
A Professional Society Overview From the American College of Cardiology, the American Association for Thoracic Surgery, Society for Cardiovascular Angiography and Interventions Foundation, and The Society of Thoracic Surgeons O’Gara PT1, Calhoon JH, Moon MR, Tommaso CL. 2014;83(6):849‐63 http://content.onlinejacc.org/article.aspx?articleid=1785971 Other Causes of Cardiomyopathy 1.
Myocarditis. Cooper LT Jr. N Engl J Med. 2009 Apr 9;360(15):1526‐38. Review. No abstract available. Full article: http://content.nejm.org/cgi/content/extract/360/15/1526 2.
Update on myocarditis. Kindermann et al. J Am Coll Cardiol. 2012;59:779‐792. http://tinyurl.com/84kbzr2 Diagnosis and management of the cardiac amyloidoses. Falk RH. Circulation. 2005;112:2047‐60. http://circ.ahajournals.org/content/112/13/2047.long Infiltrative cardiovascular diseases. Seward JB and Casaclang‐Verzosa G. J Am Coll Cardiol. 2010;55:1769‐79. http://tinyurl.com/7wvgzoq 3.
4.
Pulmonary Hypertension 1.
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult‐‐a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, Gomberg‐Maitland M, Murali S, Frantz RP, McGlothlin D, Horn EM, Benza RL. J Heart Lung Transplant. 2012 Sep;31(9):913‐33. http://www.jhltonline.org/article/S1053‐2498(12)01124‐2/fulltext Right Heart Failure 1.
2.
Pulmonary heart disease: The heart‐lung interaction and its impact on patient phenotypes Forfia PR, Vaidya A, Wiegers SE. Pulm Circ. 2013 Jan‐Mar; 3(1): 5–19. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641739/ Definitions and diagnosis of pulmonary hypertension Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42‐50 http://www.ncbi.nlm.nih.gov/pubmed/24355641 Page 7 of 8 RECOMMENDED READING LIST 2015 HFSA Comprehensive Review and Update The Practical Management of Heart Failure – From Prevention to Advanced Disease October 22‐25, 2015  Tampa, FL 3.
4.
5.
6.
Recent Advances in Pulmonary Hypertension ‐ Clinical Diagnosis of Pulmonary Hypertension Jonathan D. Rich, MD; Stuart Rich, MD. Circulation. 2014; 130: 1820-1830
http://circ.ahajournals.org/content/130/20/1820.short Contemporary Reviews in Cardiovascular Medicine Pulmonary Hypertension Due to Left Heart Disease M, Barry A. Borlaug BA Circulation.2012; 126:975‐990
http://circ.ahajournals.org/content/126/8/975.full.pdf Medical and surgical treatment of acute right ventricular failure. Lahm T, McCaslin CA, Wozniak TC, Ghumman W, Fadl YY, Obeidat OS, Schwab K, Meldrum DR. J Am Coll Cardiol. 2010 Oct 26;56(18):1435‐46 http://www.ncbi.nlm.nih.gov/pubmed/20951319 Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. Vonk‐Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22‐33 http://www.ncbi.nlm.nih.gov/pubmed/24355638 Page 8 of 8 RECOMMENDED READING LIST